0001035267-18-000121.txt : 20180910 0001035267-18-000121.hdr.sgml : 20180910 20180910104819 ACCESSION NUMBER: 0001035267-18-000121 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180907 FILED AS OF DATE: 20180910 DATE AS OF CHANGE: 20180910 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Friedman Michael A CENTRAL INDEX KEY: 0001298083 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30713 FILM NUMBER: 181061749 MAIL ADDRESS: STREET 1: 28903 NORTH AVENUE PAINE CITY: VALENCIA STATE: CA ZIP: 91355 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INTUITIVE SURGICAL INC CENTRAL INDEX KEY: 0001035267 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 770416458 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1020 KIFER ROAD CITY: SUNNYVALE STATE: CA ZIP: 94086 BUSINESS PHONE: 4085232100 MAIL ADDRESS: STREET 1: 1020 KIFER ROAD CITY: SUNNYVALE STATE: CA ZIP: 94086 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2018-09-07 0 0001035267 INTUITIVE SURGICAL INC ISRG 0001298083 Friedman Michael A 1020 KIFER ROAD SUNNYVALE CA 94086 1 0 0 0 Common Stock 2018-09-07 4 M 0 1545 271.4833 A 5964 D Common Stock 2018-09-07 4 S 0 1545 541.4588 D 4419 D Common Stock 2018-09-07 4 M 0 525 185.7333 A 4944 D Common Stock 2018-09-07 4 S 0 525 541.4588 D 4419 D Non-Qualified Stock Option (right to buy) 185.7333 2018-09-07 4 M 0 525 0.0 D 2025-07-23 Common Stock 525 0 D Non-Qualified Stock Option (right to buy) 271.4833 2018-09-07 4 M 0 1545 0.0 D 2027-04-20 Common Stock 1545 0 D This transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 6, 2019. Non-statutory stock option granted pursuant to the Non-Employee Directors' Stock Option Plan. Option shall vest 1/3rd one year after the date of grant and 1/36th each month thereafter. Non-statutory stock option granted pursuant to the Non-Employee Directors' Stock Option Plan. Option shall vest 100% one year after the date of grant or at the next Shareholders Meeting, whichever should take place first, provided that vesting will cease on termination of the Directors service to the Company. By: Lori Serrano For: Michael A Friedman 2018-09-10